We came across a bullish thesis on Sellas Life Sciences Group Inc (SLS) on ValueInvestorsClub by ContraMundem. In this article we will summarize the bulls' thesis on SLS. Sellas Life Sciences shares were trading at $1.45 when this thesis was published, vs. closing price of $1.26 on Sep 17.
[caption id="attachment_1238850" align="aligncenter" width="905"]Sellas Life Sciences (SLS) is a biotech company making waves in the cancer treatment arena with its promising pipeline and unique approach...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.